Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Kida · SciRah

Researcher profile · Semantic Scholar

K. Kida

Share profile

K. Kida — researcher profile on SciRah

h-index: 13
Works: 61
Citations: 514

Most-cited papers

Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness
H. Shima, K. Kida, Shoko Adachi, A. Yamada +10 more
2018Breast Cancer Research and Treatment85 citations
Semantic Scholar
ABCC1-exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1 Shortens Survival of Mice and Patients with Breast Cancer
A. Yamada, M. Nagahashi, T. Aoyagi, Wei‐Ching Huang +14 more
2018Molecular Cancer Research69 citations Open access
Semantic Scholar
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
K. Kida, T. Ishikawa, A. Yamada, K. Shimada +7 more
2016Breast Cancer Research and Treatment58 citations
Semantic Scholar
EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy
Fanny Le Du, T. Fujii, K. Kida, D. Davis +9 more
2020PLoS ONE39 citations Open access
Semantic Scholar
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast
Takafumi Kondō, N. Hayashi, S. Ohde, Koyu Suzuki +10 more
2015Journal of Surgical Oncology37 citations
Semantic Scholar
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
K. Narui, Takashi Ishikawa, T. Satake, Shoko Adachi +9 more
2015European Journal of Surgical Oncology32 citations
Semantic Scholar
Optimal Supportive Care for Patients With Metastatic Breast Cancer According to Their Disease Progression Phase.
K. Kida, I. Olver, Sriram Yennu, D. Tripathy +1 more
2021JCO Oncology Practice25 citations Open access
Semantic Scholar
A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
K. Kida, Takashi Ishikawa, A. Yamada, D. Shimizu +4 more
2015European Journal of Surgical Oncology20 citations
Semantic Scholar
Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.
K. Narui, T. Ishikawa, D. Shimizu, A. Yamada +23 more
2019Breast17 citations
Semantic Scholar
Change in sonographic brightness can predict pathological response of triple-negative breast cancer to neoadjuvant chemotherapy
N. Matsuda, K. Kida, S. Ohde, Koyu Suzuki +3 more
2017Breast Cancer15 citations
Semantic Scholar
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
S. Sasada, Naoto Kondo, Hiroya Hashimoto, Yuko Takahashi +16 more
2023Breast Cancer Research and Treatment14 citations Open access
Semantic Scholar
The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
T. Iwase, Aaroh M. Parikh, S. Dibaj, Yu Shen +9 more
2021Cancers14 citations Open access
Semantic Scholar
BRCAness is beneficial for indicating triple negative breast cancer patients resistant to taxane.
Takashi Ishikawa, K. Narui, M. Tanabe, K. Kida +4 more
2016European Journal of Surgical Oncology14 citations
Semantic Scholar
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer
K. Kida, A. Yamada, K. Shimada, K. Narui +6 more
2024Breast Cancer13 citations Open access
Semantic Scholar
Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of axonal damage, as a marker of chemotherapy-induced peripheral neuropathy.
M. Sumitani, T. Ogata, A. Natori, Jun Hozumi +4 more
2016Biomedical Reports10 citations Open access
Semantic Scholar
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
T. Iwase, K. Harano, H. Masuda, K. Kida +10 more
2020BMC Cancer9 citations Open access
Semantic Scholar
Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy
T. Iwase, Evan N Cohen, Hui Gao, Angela Alexander +17 more
2024Clinical Cancer Research7 citations
Semantic Scholar
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review
S. Chainitikun, J. R. Espinosa Fernández, J. Long, T. Iwase +6 more
2021PLoS ONE6 citations Open access
Semantic Scholar
Abstract P3-09-12: Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory breast cancer (mIBC) and non-IBC triple negative breast cancer (mTNBC)
Hui Gao, K. Kida, E. Cohen, Angela Alexander +8 more
2020Poster Session Abstracts6 citations
Semantic Scholar
The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccination
Kiyoko Mukai, H. Tsunoda, R. Imai, Akiko Numata +6 more
2023Japanese Journal of Radiology5 citations Open access
Semantic Scholar
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis
A. Yamada, Chiho Suzuki, H. Shima, K. Kida +12 more
2020Anticancer Research4 citations Open access
Semantic Scholar
Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy
T. Iwase, Aaroh M. Parikh, Wen-Li Dong, Yu Shen +15 more
2024Journal of Cancer3 citations Open access
Semantic Scholar
The Pathological Response to Anthracycline is Associated with Topoisomerase IIα Gene Amplification in the HER2 Breast Cancer Subset
T. Ishikawa, T. Sasaki, M. Tanabe, K. Narui +11 more
2014Journal of surgical sciences3 citations
Semantic Scholar
Abstract P3-02-04: Phase II study of Pembrolizumab Maintenance treatment in patients with HER2-negative inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) after response to chemotherapy
T. Iwase, Angela Alexander, Vivian Chiv, M. Kai +18 more
2023Cancer Research2 citations
Semantic Scholar
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
K. Kida, K. Hess, B. Lim, T. Iwase +9 more
2020Cancers2 citations Open access
Semantic Scholar
Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients
Chiho Suzuki, A. Yamada, Shoko Adachi, H. Shima +10 more
2021Anticancer Research1 citations Open access
Semantic Scholar
Abstract P3-10-23: Changes in the expression of HER2 and other genes in HER2-positive metastatic breast cancer induced by treatment with ado-trastuzumab emtansine and/or pertuzumab/trastuzumab
K. Kida, J. Lee, Huey Liu, B. Lim +4 more
2019Poster Session Abstracts1 citations
Semantic Scholar
[Diagnosis and Treatment of HBOC Syndrome by a Breast Surgical Oncologist].
K. Kida, M. Murai, H. Yamauchi
2017Gan to kagaku ryoho. Cancer & chemotherapy1 citations
Semantic Scholar
Abstract P2-06-16: The impact of ALDH1 on chemo-resistance and prognosis according to intrinsic subtype in breast cancers
K. Kida, T. Ishikawa, A. Yamada, K. Narui +4 more
20151 citations
Semantic Scholar
Abstract P3-14-08: A randomized phase II trial comparing docetaxel plus cyclophosphamide with epirubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy for hormone receptor-negative breast cancer. Kanagawa breast oncology group (KBOG) 1101 study
T. Ishikawa, D. Shimizu, M. Tanabe, M. Oba +17 more
20131 citations
Semantic Scholar
A randomized phase II trial comparing docetaxel plus cyclophosphamide with epirubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy for hormone receptor-negative breast cancer: Kanagawa Breast Oncology Croup (KBOG) 1101 study.
T. Ishikawa, D. Shimizu, M. Tanabe, M. Oba +16 more
20131 citations
Semantic Scholar
Abstract PO4-08-04: Comparison of Outcomes and Prognosis between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery versus Mastectomy for Breast Cancer
K. Kida, Junko Takei, Misato Suzuki, M. Okawa +4 more
2024Cancer Research0 citations
Semantic Scholar
Abstract PO4-01-09: The Prognostic Impact of Adjuvant Endocrine Therapy by Age for Patients with Small Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer
Yuko Takahashi, S. Sasada, Naoto Kondo, Hiroya Hashimoto +24 more
2024Cancer Research0 citations
Semantic Scholar
Abstract PO2-11-03: A long-term follow-up of patients who interrupted endocrine therapy to become pregnant following breast cancer surgery
Risa Kasahara, Atsuko Kitano, Fumi Akitani, Kyoko Shiota +3 more
2024Cancer Research0 citations
Semantic Scholar
Abstract P1-09-03: Impact of BRCA1/2 pathogenic variants on ipsilateral breast tumor recurrence and prognosis following breast-conserving surgery
Sakiko Kondo, K. Kida, Misato Suzuki, C. Fukano +5 more
2023Cancer Research0 citations
Semantic Scholar
Biomarker analysis of phase II pembrolizumab maintenance treatment after chemotherapy response in patients with HER2-negative inflammatory breast cancer and triple-negative breast cancer.
T. Iwase, Angela Alexander, E. Cohen, Hui Gao +16 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Current status of breast screening and support system of mammography/ultrasonography in healthy BRCA1/2 mutation carriers
Junko Takei, K. Kida, Hiroko Tsunoda, H. Yamauchi
2022Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening)0 citations Open access
Semantic Scholar
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan, an anti-HER2 antibody-drug conjugate
J. Lee, K. Kida, H. Liu, Y. J. Gi +6 more
2022European Journal of Cancer0 citations Open access
Semantic Scholar
Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy
K. Kida, H. Tsunoda, Risa Kasahara, Chika Tsutsumi +7 more
2022Cancer Research0 citations
Semantic Scholar
A prospective ultrasonographic surveillance study on the incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy following a booster shot.
K. Kida, H. Tsunoda, Risa Kasahara, C. Hirai +8 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
157P Prognostic role of BRCA mutation in patients with breast cancer
S. Endo, K. Kida, M. Suzuki, C. Fukano +4 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Abstract PS2-23: Prospective study of circulating cancer-associated macrophage-like cells (CAMLs) in obese patients with advanced breast cancer
T. Iwase, Aaroh M. Parikh, O. Şahin, A. Raghavendra +10 more
20210 citations
Semantic Scholar
Risk-Reducing Mastectomy (RRM)
R. Kotake, Y. Tsuchida, K. Kida, H. Yamauchi
20210 citations
Semantic Scholar
Abstract P5-06-10: Validation of prognostic stage and anatomic stage in the American joint committee on cancer 8th edition for inflammatory breast cancer
K. Kida, K. Hess, B. Lim, T. Iwase +10 more
2020Poster Session Abstracts0 citations
Semantic Scholar
Abstract 1158: Seven genes were closely associated with ALDH1 in triple negative breast cancer
T. Ishikawa, K. Narui, A. Yamada, K. Kida +7 more
2019Tumor Biology0 citations Open access
Semantic Scholar
A case of complicated cyst mimicking breast cancer
Y. Yoshida, H. Tsunoda, Noriko Tsukamoto, Rie Mukai +6 more
2019Choonpa Igaku0 citations
Semantic Scholar
Abstract P5-05-04: Myc as a poor prognostic marker for ER+ inflammatory breast cancer (IBC): Quantitative estrogen receptor (ER) expression analysis and gene expression analysis in ER+ IBC vs non-IBC
T. Iwase, K. Harano, H. Masuda, K. Kida +9 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Abstract P6-12-26: The axonal damage marker, serum phosphorylated neurofilament heavy subunit, as a potential marker of chemotherapy-induced neuropathy
K. Kida, M. Sumitani, T. Ogata, R. Kotake +5 more
20180 citations
Semantic Scholar
Abstract P6-07-03: Long non-coding RNA H19 promotes cancer stemness and worsen breast cancer survival
H. Shima, K. Kida, A. Yamada, S. Sugae +6 more
20180 citations
Semantic Scholar
Abstract P5-16-04: A randomized phase II neoadjuvant study comparing docetaxel and cyclophosphamide (TC) with 5-fluorouracil, epirubicin, and cyclophosphamide followed by docetaxel (FEC-D) for hormone receptor-negative breast cancer: The Kanagawa breast oncology group (KBOG) 1101 study
K. Narui, T. Ishikawa, D. Shimizu, M. Tanabe +21 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Endo×16
Invite
I. Endo — researcher profile on SciRah
A. Yamada×14
Invite
A. Yamada — researcher profile on SciRah
K. Narui×13
Invite
K. Narui — researcher profile on SciRah
Y. Ichikawa×13
Invite
Y. Ichikawa — researcher profile on SciRah

×12

Invite

T. Ishikawa — researcher profile on SciRah

Invite

M. Tanabe — researcher profile on SciRah

H. Yamauchi×12

Invite

H. Yamauchi — researcher profile on SciRah

Invite

N. Ueno — researcher profile on SciRah

Invite

T. Iwase — researcher profile on SciRah

Invite

D. Shimizu — researcher profile on SciRah

Invite

D. Tripathy — researcher profile on SciRah

Invite

S. Sugae — researcher profile on SciRah